Loss of menin in osteoblast lineage affects osteocyte-osteoclast crosstalk causing osteoporosis

  • Peng Liu
  • Sooyeon Lee
  • Jeanette Knoll
  • Alexander Rauch
  • Susanne Ostermay
  • Julia Luther
  • Nicole Malkusch
  • Ulf H Lerner
  • Mario M Zaiss
  • Mona Neven
  • Rainer Wittig
  • Martina Rauner
  • Jean-Pierre David
  • Philippe Bertolino
  • Chang X Zhang
  • Jan P Tuckermann

Abstract

During osteoporosis bone formation by osteoblasts is reduced and/or bone resorption by osteoclasts is enhanced. Currently, only a few factors have been identified in the regulation of bone integrity by osteoblast-derived osteocytes. In this study, we show that specific disruption of menin, encoded by multiple endocrine neoplasia type 1 (Men1), in osteoblasts and osteocytes caused osteoporosis despite the preservation of osteoblast differentiation and the bone formation rate. Instead, an increase in osteoclast numbers and bone resorption was detected that persisted even when the deletion of Men1 was restricted to osteocytes. We demonstrate that isolated Men1-deficient osteocytes expressed numerous soluble mediators, such as C-X-C motif chemokine 10 (CXCL10), and that CXCL10-mediated osteoclastogenesis was reduced by CXCL10-neutralizing antibodies. Collectively, our data reveal a novel role for Men1 in osteocyte-osteoclast crosstalk by controlling osteoclastogenesis through the action of soluble factors. A role for Men1 in maintaining bone integrity and thereby preventing osteoporosis is proposed.

Bibliografische Daten

OriginalspracheEnglisch
ISSN1350-9047
DOIs
StatusVeröffentlicht - 04.2017
PubMed 28106886